Correction to: The effect of various absorption enhancers on tight junction in the human intestinal Caco-2 cell line (Drug Development and Industrial Pharmacy, (2013), 39, 4, (587-592), 10.3109/03639045.2012.692376);The effect of various absorption enhancers on tight junction in the human intestinal Caco-2 cell line

Drug Development and Industrial Pharmacy

Volumn 39, Issue 4, 2013, Pages 587-592

  Yu, Qinghua ^a   Wang, Zhisheng ^a   Li, Pengcheng ^a   Yang, Qian ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Absorption enhancers; Caco 2 cell; Cytotoxicity; Paracellular permeability; Tight junction

Indexed keywords

ALCOHOL; CHOLIC ACID; CLAUDIN 1; EDETIC ACID; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLUCOSE; MENTHOL; OCCLUDIN; PENETRATION ENHANCING AGENT; PROTEIN ZO1; UVOMORULIN;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; COLORIMETRY; CYTOTOXICITY; DRUG ABSORPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MACROMOLECULE; TIGHT JUNCTION;

EID: 84874471035     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639045.2020.1818488     Document Type: Erratum

References (24)

1. Aungst BJ. (2000). Intestinal permeation enhancers. J Pharm Sci, 89:429-442.
2. Shen Y, Lu Y, Jv M, Hu J, Li Q, Tu J. (2011). Enhancing efect of Labrasol on the intestinal absorption of ganciclovir in rats. Drug Dev Ind Pharm, 37:1415-1421.
3. Madara JL. (1998). Regulation of the movement of solutes across tight junctions. Annu Rev Physiol, 60:143-159. (Pubitemid 28157868)
4. Sohi H, Ahuja A, Ahmad FJ, Khar RK. (2010). Critical evaluation of permeation enhancers for oral mucosal drug delivery. Drug Dev Ind Pharm, 36:254-282.
5. Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 65:55-63. (Pubitemid 14203433)
6. Zareie M, Rif J, Donato K, McKay DM, Perdue MH, Soderholm JD et al. (2005). Novel efects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function. Cell Microbiol, 7:1782-1797. (Pubitemid 41685271)
7. Anderson JM, Van Itallie CM. (1995). Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol, 269:G467-G475.
8. Hollander D. (1992). Te intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol, 27:721-726.
9. Nusrat A, Turner JR, Madara JL. (2000). Molecular physiology and pathophysiology of tight junctions. I V. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol, 279:G851-G857.
10. Hafejee N, Du Plessis J, Müller DG, Schultz C, Kotzé AF, Goosen C. (2001). Intranasal toxicity of selected absorption enhancers. Pharmazie, 56:882-888. (Pubitemid 33081725)
11. Chen W, Fan D, Meng L, Miao Y, Yang S, Weng Y et al. (2012). Enhancing efects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats. Drug Dev Ind Pharm, 38:104-110.
12. Enslin GM, Hamman JH, Kotze AF. (2008). Intestinal drug absorption enhancers: synergistic efects of combinations. Drug Dev Ind Pharm, 34:1343-1349.
13. Tang C, Yu J, Yin L, Yin C, Pei Y. (2007). Transport of insulin in modifed Valia-Chien chambers and Caco-2 cell monolayers. Drug Dev Ind Pharm, 33:449-456. (Pubitemid 46808780)
14. Vllasaliu D, Exposito-Harris R, Heras A, Casettari L, Garnett M, Illum L et al. (2010). Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution. Int J Pharm, 400:183-193.
15. Karlsson J, Ungell A, Gråsjö J, Artursson P. (1999). Paracellular drug transport across intestinal epithelia: infuence of charge and induced water fux. Eur J Pharm Sci, 9:47-56. (Pubitemid 29430192)
16. Turner Jr. (2000). Show me the pathway! Regulation of paracellular permeability by Na(+)-glucose cotransport. Adv Drug Deliv Rev, 41:265-281.
17. Merzlikine A, Rotter C, Rago B, Poe J, Christofersen C, Tomas VH et al. (2009). Efect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profle of acyclovir in rats. Drug Dev Ind Pharm, 35:1082-1091.
18. Ward PD, Tippin TK, Takker DR. (2000). Enhancing paracellular permeability by modulating epithelial tight junctions. Pharm Sci Technol Today, 3:346-358.
19. Anderberg EK, Artursson P. (1993). Epithelial transport of drugs in cell culture. VIII: Efects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells. J Pharm Sci, 82:392-398. (Pubitemid 23150434)
20. Bleakman D, Naftalin RJ. (1990). Hypertonic fuid absorption from rabbit descending colon in vitro. Am J Physiol, 258:G377-G390. (Pubitemid 20116447)
21. Prasad R, Anand S, Khar RK, Dinda AK, Koul V. (2009). Studies on in vitro and in vivo transdermal fux enhancement of methotrexate by a combinational approach in comparison to oral delivery. Drug Dev Ind Pharm, 35:1281-1292.
22. Sammeta SM, Repka MA, Narasimha Murthy S. (2011). Magnetophoresis in combination with chemical enhancers for transdermal drug delivery. Drug Dev Ind Pharm, 37:1076-1082.
23. Ma TY, Nguyen D, Bui V, Nguyen H, Hoa N. (1999). Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol, 276:G965-G974. (Pubitemid 29214111)
24. Miguel R. (1994). Eutetic mixture of local anesthetics: not just for kids. Reg Anesth, 19:75-76. (Pubitemid 24047231)